THURSDAY, July 28, 2016 (HealthDay News) -- Adlyxin (lixisenatide) has been approved by the U.S. Food and Drug Administration to treat type 2 diabetes in adults, the agency said Thursday in a news release.
www.stltoday.com - RSS Results in lifestyles* of type article, St. Louis Post-Dispatch: Living
Thu, 07/28/2016 - 9:34am
THURSDAY, July 28, 2016 (HealthDay News) -- Adlyxin (lixisenatide) has been approved by the U.S. Food and Drug Administration to treat type 2 diabetes in adults, the agency said Thursday in a news release.